MENUNews Archive
Date: 12/18/2020
Eight University of Michigan faculty members -- including three members of the U-M Rogel Cancer Center - have been elected 2020 fellows of the American Association for the Advancement of Science.
Date: 12/18/2020
A combination approach to treating a prevalent glioma subtype -- including metabolic reprogramming, radiation, chemotherapy and immunotherapy -- led to a complete regression of tumors in 60% of study mice.
Date: 12/15/2020
Despite the increase in use of e-cigarettes among adolescents, cigarette and smokeless tobacco prevalence declined more rapidly between 2012 and 2019 than in previous periods.
Date: 12/10/2020
Physicians did not recognize side effects from radiation therapy in more than half of breast cancer patients who reported a significant symptom, a new study finds.
Date: 10/30/2020
A new study combined single-cell RNA sequencing with two other investigative techniques to create what is believed to be the most robust and detailed portrait to date of the network of interactions that suppress the body’s immune response in and around pancreatic tumors.
Date: 10/28/2020
The U-M-led development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials.
Date: 10/26/2020
Researchers are optimistic that cerebrospinal fluid could be a valuable source for tumor DNA that could help monitor and treat pediatric cancer patients with aggressive brain tumors known as high-grade gliomas.
Date: 10/23/2020
When first- and second-line treatments have been exhausted, few options remain for patients with advanced head and neck cancer.
A new phase 2 clinical trial by researchers at the University of Michigan Rogel Cancer Center found the drug axitinib was able to extend the lives of these patients by several months, and also identified a subset of patients with a specific mutation for whom the drug is likely to work best.
Date: 10/21/2020
A team of researchers from the Rogel Cancer Center received an $11.2 million grant from the National Heart, Lung and Blood Institute to study how to use the microbiome to limit complications of stem cell transplants for blood cancers and other diseases.
Date: 10/19/2020
Today, F. DuBois Bowman, Justin B. Dimick, Christopher R. Friese, Karin M. Muraszko and Henry L. Paulson join a select group of fewer than 60 current and emeritus U-M faculty, and living former faculty, in the National Academy of Medicine. Drs. Friese and Muraszko are cancer center members.